0001209191-18-011686.txt : 20180220
0001209191-18-011686.hdr.sgml : 20180220
20180220203020
ACCESSION NUMBER: 0001209191-18-011686
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180215
FILED AS OF DATE: 20180220
DATE AS OF CHANGE: 20180220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kroll Werner
CENTRAL INDEX KEY: 0001609320
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-10961
FILM NUMBER: 18626741
MAIL ADDRESS:
STREET 1: 12544 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUIDEL CORP /DE/
CENTRAL INDEX KEY: 0000353569
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 942573850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12544 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 8585521100
MAIL ADDRESS:
STREET 1: 12544 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/
DATE OF NAME CHANGE: 19910210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-02-15
0
0000353569
QUIDEL CORP /DE/
QDEL
0001609320
Kroll Werner
12544 HIGH BLUFF DRIVE, SUITE 200
SAN DIEGO
CA
92130
0
1
0
0
SVP, R&D
Common Stock
2018-02-15
4
A
0
7171
0.00
A
13827
D
Common Stock
2018-02-15
4
F
0
2479
45.10
D
11348
D
Reporting Person acquired these shares in connection with full achievement of performance metrics associated with performance-based restricted stock units awarded on 2/15/2017.
The amount of securities beneficially owned prior to this transaction included an additional 664 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan.
Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of performance-based restricted stock units.
Robert J. Bujarski, attorney-in-fact for Werner Kroll
2018-02-20